CAMP4 THERAPEUTICS
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.
CAMP4 THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.camp4tx.com
Total Employee:
11+
Status:
Active
Contact:
617-651-8867
Email Addresses:
[email protected]
Total Funding:
190 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Euro
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Amylon Therapeutics
Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders.
Amytrx Therapeutics
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
BAMF Health
BAMF Health is a biotechnology company that designs, develops, and builds cyclotron-equipped radiopharmacies and clinics.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
CB Therapeutics
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
DeepBiome Therapeutics
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Gameto
Gameto is a biotechnology firm focused on female reproductive fertility biotech.
Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics
Nerio Therapeutics
Nerio Therapeutics is a biotechnology company focused on the life sciences sector.
Nirrin Technologies
NIRRIN Analytics is a biotechnology company that develops real-time non-destructive bioprocess monitoring systems.
Novome Biotechnologies
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
SIWA Therapeutics
SIWA Therapeutics is a biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.
TreeFrog Therapeutics
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
Ventyx Biosciences
Ventyx Biosciences is a clinical biotechnology company that intends to treat autoimmune diseases efficiently.
Vesigen Therapeutics
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Kraft Group
The Kraft Group investment in Series B - CAMP4 Therapeutics
Enavate Sciences
Enavate Sciences investment in Series B - CAMP4 Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series B - CAMP4 Therapeutics
Gaingels
Gaingels investment in Series B - CAMP4 Therapeutics
Polaris Partners
Polaris Partners investment in Series B - CAMP4 Therapeutics
Northpond Ventures
Northpond Ventures investment in Series B - CAMP4 Therapeutics
5AM Ventures
5AM Ventures investment in Series B - CAMP4 Therapeutics
Polaris Partners
Polaris Partners investment in Series A - CAMP4 Therapeutics
The Kraft Group
The Kraft Group investment in Series A - CAMP4 Therapeutics
5AM Ventures
5AM Ventures investment in Series A - CAMP4 Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-04-19 | CAMP4 Therapeutics Promotes Kelly Gold to Chief Financial Officer |
Official Site Inspections
http://www.camp4tx.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.35 K
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago